Adaptive Biotechnologies Reports First Quarter 2020 Financial Results
May 12, 2020 16:03 ET
|
Adaptive Biotechnologies
SEATTLE, May 12, 2020 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the...
Infinera Corporation Reports First Quarter 2020 Financial Results
May 12, 2020 16:03 ET
|
Infinera Corporation
SUNNYVALE, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Infinera Corporation (NASDAQ: INFN) today released financial results for its first quarter ended March 28, 2020. GAAP revenue for the quarter was...
Mark Templeton Appointed to Health Catalyst Board of Directors
May 12, 2020 16:03 ET
|
Health Catalyst, Inc.
SALT LAKE CITY, May 12, 2020 (GLOBE NEWSWIRE) -- The board of directors (the “Board”) of Health Catalyst, Inc. ("Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology...
Shockwave Medical Reports First Quarter 2020 Financial Results
May 12, 2020 16:03 ET
|
Shockwave Medical, Inc.
SANTA CLARA, Calif., May 12, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex...
Kane Biotech Reports Positive Results from Anti-Biofilm Shampoo Consumer Product Test
May 12, 2020 16:02 ET
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 12, 2020 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced positive results from a consumer product test evaluating the...
Jeffersonville Bancorp Announces First Quarter Earnings of $1,046,000 or $0.25 per share; Declares Dividend of $0.15
May 12, 2020 16:01 ET
|
Jeffersonville Bancorp
JEFFERSONVILLE, N.Y., May 12, 2020 (GLOBE NEWSWIRE) -- Jeffersonville Bancorp, Inc. (OTCQB - JFBC) announced today first quarter net income of $1,046,000 or $0.25 per share compared to $1,676,000 or...
Satsuma Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
May 12, 2020 16:01 ET
|
Satsuma Pharmaceuticals
STS101 EMERGE™ Phase 3 efficacy trial remains on track with announcement of topline data expected in second half of 2020 Company well-capitalized with cash, cash equivalents, and marketable...
Vaxart Announces First Quarter 2020 Financial Results and Provides Corporate Update
May 12, 2020 16:01 ET
|
Vaxart, Inc.
Lead Vaccine Candidates for COVID-19 are Highly Immunogenic in Preclinical Testing COVID-19 Phase 1 Clinical Study Planned for 2H20 SOUTH SAN FRANCISCO, Calif., May 12, 2020 (GLOBE NEWSWIRE) --...
Cambium Networks Reports First Quarter 2020 Financial Results
May 12, 2020 16:01 ET
|
Cambium Networks
Revenues of $60.4 million, above the high-end of outlookEnterprise Wi-Fi revenues, increased 106% year-over-yearGross margin of 50.7%, non-GAAP(1) gross margin of 51.0%Net loss of $0.8 million or...
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2020 Financial Results
May 12, 2020 16:01 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, May 12, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today...
- September 27, 2024 16:43 ET Hampton University Fuels Half-Billion-Dollar Economic Boost to Hampton Roads
- September 27, 2024 15:00 ET Ozan Ardic Embarks on Debut Canada-Wide Concert Tour